摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5'-methoxy-2'-(3-methoxybenzyl)biphenyl-4-ol | 679410-62-9

中文名称
——
中文别名
——
英文名称
5'-methoxy-2'-(3-methoxybenzyl)biphenyl-4-ol
英文别名
4-[5-methoxy-2-[(3-methoxyphenyl)methyl]phenyl]phenol
5'-methoxy-2'-(3-methoxybenzyl)biphenyl-4-ol化学式
CAS
679410-62-9
化学式
C21H20O3
mdl
——
分子量
320.388
InChiKey
QAJQBTBTOQGXNR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.1
  • 重原子数:
    24
  • 可旋转键数:
    5
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    38.7
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    5'-methoxy-2'-(3-methoxybenzyl)biphenyl-4-ol吡啶盐酸盐 、 sodium hydride 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 生成 6-(3-hydroxybenzyl)-4'-(2-piperidin-1-ylethoxy)biphenyl-3-ol
    参考文献:
    名称:
    A New Series of Estrogen Receptor Modulators: Effect of Alkyl Substituents on Receptor-Binding Affinity
    摘要:
    新型选择性雌激素受体调节剂(SERMs)被合成并评估其与生殖细胞的结合亲和力和生物学效应。提议的先导结构(B)被衍生化以提供化合物30和44,这些化合物显示出良好的雌激素受体结合亲和力(Ki值:分别为6.3和10 nM),同时对乳腺癌和子宫癌细胞的影响较小。核心结构中引入烷基基团显著增强了测试化合物的受体结合亲和力。文中描述了这些化合物的合成及其结构–活性关系。
    DOI:
    10.1248/cpb.52.79
  • 作为产物:
    描述:
    4'-Benzyloxy-5-methoxy-2-(3-methoxybenzyl)biphenyl 在 palladium on activated charcoal 氢气 作用下, 以 四氢呋喃 为溶剂, 反应 1.0h, 以167 mg的产率得到5'-methoxy-2'-(3-methoxybenzyl)biphenyl-4-ol
    参考文献:
    名称:
    A New Series of Estrogen Receptor Modulators: Effect of Alkyl Substituents on Receptor-Binding Affinity
    摘要:
    新型选择性雌激素受体调节剂(SERMs)被合成并评估其与生殖细胞的结合亲和力和生物学效应。提议的先导结构(B)被衍生化以提供化合物30和44,这些化合物显示出良好的雌激素受体结合亲和力(Ki值:分别为6.3和10 nM),同时对乳腺癌和子宫癌细胞的影响较小。核心结构中引入烷基基团显著增强了测试化合物的受体结合亲和力。文中描述了这些化合物的合成及其结构–活性关系。
    DOI:
    10.1248/cpb.52.79
点击查看最新优质反应信息

文献信息

  • Selective Estrogen Receptor Modulator
    申请人:Hamaoka Shinichi
    公开号:US20120004315A1
    公开(公告)日:2012-01-05
    The present invention provides a compound represented by the following formula (I); [wherein T represents a single bond, a C1-C4 alkylene group which may have a substituent and the like; formula (I-1) represents a single bond or a double bond; A represents a single bond, a bivalent 5- to 14-membered heterocyclic group which may have a substituent and the like; Y represents a single bond and the like; Z represents a methylene group and the like; ring G represents a phenylene group and the like which may condense with a 5- to 6-membered ring and may have a heteroatom; R a and R b are the same as or different from each other and represent a hydrogen atom and the like; W represents a single bond and the like; R′ represents 1 to 4 independent hydrogen atoms and the like; and R″ represents 1 to 4 independent hydrogen atoms and the like] or a salt thereof, or a hydrate thereof.
    本发明提供一种由以下式(I)表示的化合物; [其中T表示单键,可能具有取代基的C1-C4烷基和类似物;式(I-1)表示单键或双键;A表示单键,可能具有取代基的双价5-至14-成员杂环基和类似物;Y表示单键和类似物;Z表示亚甲基基团和类似物;环G表示苯基团和类似物,可能与5-至6-成员环缩合并可能具有杂原子;Ra和Rb相同或不同,表示氢原子和类似物;W表示单键和类似物;R'表示1到4个独立的氢原子和类似物;R''表示1到4个独立的氢原子和类似物]或其盐或合物。
  • Selective estrogen receptor modulator
    申请人:Hamaoka Shinichi
    公开号:US20060116364A1
    公开(公告)日:2006-06-01
    The present invention provides a compound represented by the following formula [wherein T represents a single bond, a C1-C4 alkylene group which may have a substituent and the like; formula (I-1) represents a single bond or a double bond; A represents a single bond, a bivalent 5- to 14-membered heterocyclic group which may have a substituent and the like; Y represents a single bond and the like; Z represents a methylene group and the like; ring G represents a phenylene group and the like which may condense with a 5- to 6-membered ring and may have a heteroatom; R a and R b are the same as or different from each other and represent a hydrogen atom and the like; W represents a single bond and the like; R′ represents 1 to 4 independent hydrogen atoms and the like; and R″ represents 1 to 4 independent hydrogen atoms and the like] or a salt thereof, or a hydrate thereof
    本发明提供了一种化合物,其表示为以下式子[其中T表示单键,C1-C4的烷基,可能带有取代基等;式(I-1)表示单键或双键;A表示单键,二价的5-至14-成员杂环基团,可能带有取代基等;Y表示单键等;Z表示亚甲基等;环G表示苯基团等,可与5-至6-成员环缩合并且可能具有杂原子;Ra和Rb相同或不同,表示氢原子等;W表示单键等;R'表示1至4个独立的氢原子等;R"表示1至4个独立的氢原子等]或其盐,或其合物。
  • SELECTIVE ESTROGEN RECEPTOR MODULATOR
    申请人:Hamaoka Shinichi
    公开号:US20090325930A1
    公开(公告)日:2009-12-31
    The present invention provides a compound represented by the following formula (I); [wherein T represents a single bond, a C1-C4 alkylene group which may have a substituent and the like; (I-1) formula (I-1) represents a single bond or a double bond; A represents a single bond, a bivalent 5- to 14-membered heterocyclic group which may have a substituent and the like; Y represents a single bond and the like; Z represents a methylene group and the like; ring G represents a phenylene group and the like which may condense with a 5- to 6-membered ring and may have a heteroatom; R a and R b are the same as or different from each other and represent a hydrogen atom and the like; W represents a single bond and the like; R′ represents 1 to 4 independent hydrogen atoms and the like; and R″ represents 1 to 4 independent hydrogen atoms and the like] or a salt thereof, or a hydrate thereof.
    本发明提供了一种由以下式(I)表示的化合物;[其中,T表示单键,C1-C4烷基,可以有取代基等;(I-1)式(I-1)表示单键或双键;A表示单键,双价的5-至14-成员杂环基,可以有取代基等;Y表示单键等;Z表示亚甲基等;环G表示苯基等,可以与5-至6-成员环缩合,可以有杂原子;Ra和Rb相同或不同,表示氢原子等;W表示单键等;R′表示1至4个独立的氢原子等;R″表示1至4个独立的氢原子等]或其盐,或其合物。
  • SELECTIVE ESTROGEN RECEPTOR MODULATORS
    申请人:Eisai Co., Ltd.
    公开号:EP1577288A1
    公开(公告)日:2005-09-21
    The present invention provides a compound represented by the following formula (I); [wherein T represents a single bond, a C1-C4 alkylene group which may have a substituent and the like; formula (I-1) represents a single bond or a double bond; A represents a single bond, a bivalent 5- to 14-membered heterocyclic group which may have a substituent and the like; Y represents a single bond and the like; Z represents a methylene group and the like; ring G represents a phenylene group and the like which may condense with a 5- to 6-membered ring and may have a heteroatom; Ra and Rb are the same as or different from each other and represent a hydrogen atom and the like; W represents a single bond and the like; R' represents 1 to 4 independent hydrogen atoms and the like; and R" represents 1 to 4 independent hydrogen atoms and the like] or a salt thereof, or a hydrate thereof.
    本发明提供了由下式(I)代表的化合物; [其中 T 代表单键、可能具有取代基的 C1-C4 亚烷基等; 式(I-1)代表单键或双键;A 代表单键、可具有取代基等的二价 5 至 14 元杂环基团;Y 代表单键等;Z 代表亚甲基等;环 G 代表可与 5 至 6 元环缩合且可具有杂原子的亚苯基等;Ra和Rb彼此相同或不同,代表氢原子等;W代表单键等;R'代表1至4个独立氢原子等;R "代表1至4个独立氢原子等]或其盐或其合物。
  • Selective estrogen receptor modulators
    申请人:Eisai R&D Management Co., Ltd.
    公开号:EP1577288B1
    公开(公告)日:2014-07-23
查看更多

同类化合物

(11aR)-3,7-双(3,5-二甲基苯基)-10,11,12,13-四氢-5-羟基-5-氧化物-二茚基[7,1-de:1'',7''-fg][1,3,2]二氧杂膦酸 龙血素C 顺-1,7-二苯基-1-庚烯基-5-醇 那洛西芬 赤杨酮 赤杨二醇 血竭素 蒙桑酮C 萘-2,7-二磺基酸,钠盐 苯酚,4-(1,3-二苯基丁基)-2-(1-苯基乙基)- 苯甲酸,2-[[2-[(2-羧基苯基)氨基]-5-(三氟甲基)苯基]氨基]-5-[[[(4-羟基-3-甲氧苯基)甲基]氨基]甲基]- 苯基-[4-(2-苯基乙炔基)苯基]甲酮 苯基-[2-[3-(三氟甲基)苯基]苯基]甲酮 苯基-[2-(2-苯基苯基)苯基]甲酮 苯基-(3-苯基萘-2-基)甲酮 苯基-(2-苯基环己基)甲酮 苯,[(二甲基苯基)甲基]甲基[(甲基苯基)甲基]- 苯,1,3-二[1-甲基-1-[4-(4-硝基苯氧基)苯基]乙基]- 脱甲氧姜黄 紫外吸收剂 234 粗糠柴苦素 硫酸姜黄素 矮紫玉盘素 益智醇 白桦林烯酮;1,7-双(4-羟基苯基)-4-庚烯-3-酮 甲酮,苯基(1,6,7,8-四氢-1-甲基-5-苯基环戊二烯并[g]吲哚-3-基)- 甲酮,[3-(4-甲氧苯基)-1-苯基-9H-芴-4-基]苯基- 甲酮,(4-氯苯基)[1-(4-氯苯基)-3-苯基-9H-芴-4-基]- 环香草酮 溴敌隆 波森 桤木酮 桑根酮D 杨梅醇 杨梅酮 杨梅联苯环庚醇-15-葡糖苷 替拉那韦 替吡法尼(S型对映体) 替吡法尼 曲沃昔芬 姜黄素葡糖苷酸 姜黄素beta-D-葡糖苷酸 姜黄素4,4'-二乙酸酯 姜黄素-d6 姜黄素 姜烯酮 A 奈帕芬胺杂质D 四甲基姜黄素 四氢脱甲氧基二阿魏酰甲烷 四氢姜黄素二乙酸酯